Screening Protocol for Children and Adolescents With Attention Deficit Hyperactivity Disorder

The ADHD Clinical Research Program at Massachusetts General Hospital currently offers a
range of protocols addressing different aspects of ADHD in children and adolescents.
Although these protocols have received prior IRB approval, potential participants present
with a widely varied set of complaints not always discernable in a telephone screening
interview. This state of affairs often makes it difficult to ask subjects and their parents
to sign a specific protocol's consent form without obtaining additional clinical
information. Because of this, we are proposing that potential subjects and their parents
undergo an in-depth clinical assessment that will allow them to be screened by a clinician
for eligibility to a diverse clinical research program.

Inclusion Criteria:

1. Males and females ages 6-17

2. Family/guardian contacting the Clinical Research Program in Pediatric
Psychopharmacology, with concerns regarding ADHD symptoms in his/her child

Exclusion Criteria:

1. History of significant head trauma with loss of consciousness, organic brain
disorders, seizures, or neurological intervention

2. Any significant medical condition, in the judgment of the investigator

3. Mental retardation

4. Pregnancy or lactation

5. Subjects with current, uncontrolled (within the past 3 months) illicit drug or
alcohol dependence

6. Sensory difficulties such as deafness or blindness